PDUFA dates October 2023: FDA calendar and catalysts.
0 PDUFA dates fell in October 2023. The FDA calendar also recorded 40 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
PDUFA dates in October 2023
No PDUFA dates are disclosed for this period as of November 16, 2026.
Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months
October 2023: other FDA decisions and filings
October 2023: dated readouts
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| Oct 2023Month disclosed | Chenodal | MIRM | Topline readout | — | Positive | SEC Form 10-Q |
| Oct 2023Month disclosed | — | MLTX | Topline readout | moderate-to-severe HS | Positive | SEC Form 10-Q |
| Oct 2023Month disclosed | — | QUCY | Topline readout | — | Positive | sec_424b |
| October 9, 2023 | vidofludimus | IMUX | Interim readout | — | Positive | sec_424b |
| October 30, 2023 | brilaroxazine | RVPH | Topline readout | schizophrenia | Positive | sec_424b |
| October 30, 2023 | — | RVPH | Topline readout | — | Positive | sec_424b |
| October 31, 2023 | HLP003 | HELP | Interim readout | moderate to severe MDD | Met primary endpoint | SEC 8-K Exhibit 99.1 |
| October 31, 2023 | CYB003 | HELP | Interim readout | moderate to severe MDD | Met primary endpoint | SEC 8-K Exhibit 99.1 |
October 2023: trial starts and primary completions
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| Oct 2023Month disclosed | ELI-002 | ELTX | Trial start | — | Completed | SEC Form 10-Q |
| Oct 2023Month disclosed | rezpegaldesleukin (NKTR-358) | NKTR | Trial start | moderate-to-severe atopic dermatitis | Completed | SEC Form 10-Q |
| Oct 2023Month disclosed | ISEMBYLD (apitegromab) | SRRK | Trial start | — | Completed | SEC Form 10-Q |
| Oct 2023Month disclosed | TARA-002 | TARA | Trial start | macrocystic and mixed-cystic LMs | Completed | SEC Form 10-K |
| Oct 2023Month disclosed | BDC-3042 | BOLT | Trial start | broad range of solid tumors | Completed | SEC Form 10-Q |
| Oct 2023Month disclosed | DT-216 | DSGN | Trial start | — | Completed | SEC Form 10-Q |
| Oct 2023Month disclosed | DISC-3405 | IRON | Trial start | — | Completed | SEC Form 10-Q |
| Oct 2023Month disclosed | efzofitimod (ATYR1923) | ATYR | Trial start | — | Completed | sec_424b |
| Oct 2023Month disclosed | FIT-001 | KURA | Trial start | — | Completed | SEC Form 10-K |
Questions
What PDUFA dates are in October 2023?
0 PDUFA dates fell in October 2023. The FDA calendar also recorded 40 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
Can these dates change?
Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.